Sarepta Therapeutics, Inc.
SRPT
$18.84
-$0.29-1.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 653.19M | 939.65M | 850.99M | 800.14M | 522.76M |
| Total Receivables | 547.91M | 519.61M | 541.60M | 609.60M | 724.52M |
| Inventory | 1.00B | 914.74M | 1.08B | 994.04M | 941.43M |
| Prepaid Expenses | 28.61M | 29.24M | 29.85M | 34.26M | 29.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 79.05M | 134.69M | 222.70M | 218.96M | 214.51M |
| Total Current Assets | 2.31B | 2.54B | 2.72B | 2.66B | 2.43B |
|
|
|||||
| Total Current Assets | 2.31B | 2.54B | 2.72B | 2.66B | 2.43B |
| Net Property, Plant & Equipment | 460.30M | 470.62M | 498.10M | 514.90M | 507.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 31.38M | 28.95M | 29.68M | 30.52M | 26.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 287.64M | 301.63M | 234.14M | 435.68M | 387.41M |
| Total Assets | 3.18B | 3.35B | 3.49B | 3.68B | 3.47B |
|
|
|||||
| Total Accounts Payable | 70.38M | 280.84M | 94.02M | 136.70M | 156.11M |
| Total Accrued Expenses | 174.30M | 237.39M | 157.68M | 205.24M | 178.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.38M | 11.20M | 10.17M | 10.42M | 12.97M |
| Total Finance Division Other Current Liabilities | 244.11M | 565.87M | 659.56M | 567.59M | 257.74M |
| Total Other Current Liabilities | 244.11M | 565.87M | 659.56M | 567.59M | 257.74M |
| Total Current Liabilities | 499.16M | 1.10B | 921.43M | 919.95M | 605.59M |
|
|
|||||
| Total Current Liabilities | 499.16M | 1.10B | 921.43M | 919.95M | 605.59M |
| Long-Term Debt | 838.16M | 828.97M | 1.04B | 1.14B | 1.14B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 198.51M | 199.38M | 215.04M | 214.42M | 205.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 138.00M | 85.44M | 1.70M | 48.60M | 373.33M |
| Total Liabilities | 1.67B | 2.21B | 2.17B | 2.32B | 2.32B |
|
|
|||||
| Common Stock & APIC | 6.08B | 6.04B | 5.99B | 5.84B | 5.80B |
| Retained Earnings | -4.55B | -4.88B | -4.64B | -4.46B | -4.66B |
| Treasury Stock & Other | -25.38M | -24.99M | -25.04M | -25.31M | 34.00K |
| Total Common Equity | 1.51B | 1.14B | 1.32B | 1.36B | 1.14B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.51B | 1.14B | 1.32B | 1.36B | 1.14B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.51B | 1.14B | 1.32B | 1.36B | 1.14B |
|
|
|||||